PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, announced today that it has priced an offering of $500,000,000 aggregate principal amount of 5.00% senior notes due 2021 at an issue price of 99.372% of the principal amount.
The issuance of the notes is expected to close on October 25, 2011. The notes will pay interest on a semi-annual basis.
The company plans to use the proceeds of the offering to fund, in part, the company’s acquisition of Caliper Life Sciences, Inc. (NASDAQ: CALP). The aggregate purchase price of the Caliper acquisition is estimated to be approximately $600 million net of acquired cash. The Caliper acquisition has been separately announced by the company.
The joint book-running managers for the offering are Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays Capital Inc. and Deutsche Bank Securities Inc.
PerkinElmer has filed a registration statement on Form S-3 (including a prospectus) with the Securities and Exchange Commission (the “SEC”). Prospective investors should read the prospectus forming a part of that registration statement and the preliminary prospectus supplement related to the offering and the other documents that the company has filed with the SEC for more complete information about the company and this offering. These documents are available at no charge by visiting EDGAR on the SEC Website at www.sec.gov. Alternatively, these documents will be made available upon request by the company or by any underwriter or dealer participating in the offering. Interested parties may obtain a prospectus or the related preliminary prospectus supplement from Merrill Lynch, Pierce, Fenner & Smith Incorporated by directing a request to firstname.lastname@example.org, or by calling 1-800-294-1322; or from Barclays Capital Inc. by directing a request to Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, New York, NY 11717, or by calling 1-888-603-5847; or from Deutsche Bank Securities Inc. by directing a request to 100 Plaza One, Floor 2, Jersey City, NJ, 07311-3901, Attn: Prospectus Department, or via email at email@example.com, or by calling 1-800-503-4611.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the notes, nor shall there be any offer, solicitation or sale of the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $1.7 billion in 2010, has about 6,200 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
David C. Francisco, 781-663-5677
Vice President, Investor Relations
Stephanie R. Wasco, 781-663-5701
Vice President, Corporate Communications
Mario Fante, 781-663-5602
Corporate Public Relations Manager
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here